Epigallocatechin-3-gallate-induced vascular normalization in A549-cell xenograft-bearing nude mice: therapeutic efficacy in combination with chemotherapy
Pengbo Deng, Chengping Hu, Zeng Xiong, Yuanyuan Li, Juan Jiang, Huaping Yang, Yongjun Tang, Liming Cao, Rongli Lu Department of Respiratory Medicine, Key Site of National Clinical Research Center for Respiratory Diseases, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China Purp...
Main Authors: | Deng P, Hu C, Xiong Z, Li Y, Jiang J, Yang H, Tang Y, Cao L, Lu R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-03-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/epigallocatechin-3-gallate-induced-vascular-normalization-in-a549-cell-peer-reviewed-article-CMAR |
Similar Items
-
Characterization of the Synergistic Antioxidant Activity of Epigallocatechin Gallate (EGCG) and Kaempferol
by: Qiang Zhang, et al.
Published: (2023-07-01) -
The Potential Roles of Epigallocatechin-3-Gallate in the Treatment of Ovarian Cancer: Current State of Knowledge
by: Bimonte S, et al.
Published: (2020-10-01) -
Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer
by: Saleh A. Almatroodi, et al.
Published: (2020-07-01) -
Evaluation of chemopreventive effects in colitis-associated colon tumourigenesis and oral toxicity of the lipophilic epigallocatechin gallate-docosahexaenoic acid
by: Yi-Shiou Chiou, et al.
Published: (2016-06-01) -
Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts
by: Ran Wei, et al.
Published: (2019-10-01)